Patient Monitoring Device/Equipment/System Market - Global Forecast to 2020

Attributed to the Rising Prevalence of Neuro-degenerative Diseases, the Patient Monitoring Market in the Neuromonitoring Segment Will Be the Fastest Growing Segment in the Next Five Years

The patient monitoring devices market is expected to grow at a CAGR of 5.6% to reach USD 24,762 million by 2020.
The patient monitoring devices form an indispensible part of medical team for every procedure, whether operating in a small clinic or a large multi-specialty hospital. Advanced technology has reduced the size of these monitors drastically with the latest devices being mere grain sized implants. The rising adoption of telemetry and remote monitoring has fueled the growth of patient monitoring devices. The capacity of these devices to monitor patients from long distance, perform intra-operative procedures, and prescribe treatments to patients has reduced discomfort for patients, which has also reduced the hospital stays for patients and reduced the physicians’ need to travel.

The cardiac monitors segment had the largest share of the total patient monitoring devices market in 2015 and will continue to grow in the next five years to retain the leading position in 2020. The high growth in this segment is attributed to the growing demand for ECG devices. Moreover, rising incidences of cardiac and diseases such as diabetes and hypertension have also contributed to the largest share of the cardiac monitors market. Multi-parameter monitoring devices market was the second largest segment in 2015. These devices can monitor various physiological parameters of a patient in order to have an overview of the patients’ health and status. Due to the tremendous increase in the number of hospitalizations, ranging from extremely serious to basic monitoring, hospitals are increasing the investment in the multi-parameter monitoring devices.

The neuromonitoring devices segment, on the other hand, will be the fastest growing segment in the coming years. With the evolution in technology, neuromonitoring devices can predict the occurrence of neurodegenerative diseases. With growing incidences and increasing awareness of neurodegenerative diseases this market is set to grow at a fast pace. The respiratory monitors segment is also expected to grow at a high pace in the forecast period. Under this segment the capnography products were the fastest growing among all the sub-segments of patient monitoring. Growing number of alternate use of capnographs is the major factor driving the growth of the market. Here the use of capnograph is not limited for intubated patients only but is used for measuring breathing in non-intubated patients. The Remote Patient Monitoring (RPM) devices segment is also poised to grow at a high pace in the coming years, driven by the strict government regulations to restrain the rising healthcare costs.


From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data of the various segments in this industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives by governments. The competitive landscape covers the growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on the key players in the patient monitoring devices market and the strategies adopted by them to maintain and increase their market shares in the near future. The above mentioned market research data, current market size, and forecast of the future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on patient monitoring devices offered by top 10 players in the market. The report analyzes the patent patient monitoring devices market by product and end user across geographies

‧ Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the patient monitoring devices market

‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various patient monitoring devices across geographies

‧ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the patient monitoring devices market

‧ Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the patient monitoring devices market

TABLE OF CONTENTS

1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 MARKET SCOPE 22
1.3.1 MARKETS COVERED 22
1.3.2 YEARS CONSIDERED FOR THE STUDY 24
1.4 CURRENCY 24
1.5 STAKEHOLDERS 24
2 RESEARCH METHODOLOGY 25
2.1 MARKET SIZE ESTIMATION 26
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.2.1 KEY DATA FROM SECONDARY SOURCES 29
2.2.2 KEY DATA FROM PRIMARY SOURCES 29
2.2.2.1 Key Industry Insights 30
2.2.3 ASSUMPTIONS 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 35
4.1 PATIENT MONITORING DEVICES MARKET TO GROW AT A STEADY RATE DURING THE FORECAST PERIOD 35
4.2 PATIENT MONITORING MARKET, BY PRODUCT 36
4.3 PATIENT MONITORING MARKET, BY PRODUCT & REGION 36
5 MARKET OVERVIEW 39
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 DRIVERS 41
5.2.1.1 Increasing geriatric population to propel the demand for monitoring devices 41
5.2.1.2 Rising incidence of lifestyle diseases 41
5.2.1.3 Growing preference for home and remote monitoring 41
5.2.1.4 Ease-of-use and portability of devices to encourage adoption of point-of-care monitoring devices 41
5.2.2 RESTRAINTS 42
5.2.2.1 Dearth of skilled professionals in patient monitoring 42
5.2.3 OPPORTUNITIES 42
5.2.3.1 Private institutional nursing 42
5.2.3.2 Mergers, acquisitions, and joint ventures 43
5.2.4 CHALLENGES 43
5.2.4.1 Irregular reimbursement scenario 43
6 HEMODYNAMIC MONITORING DEVICES 44
6.1 INTRODUCTION 45
6.1.1 BLOOD PRESSURE MONITORS 46
6.1.2 BLOOD GLUCOSE MONITORS 50
6.1.3 BLOOD GAS AND ELECTROLYTE ANALYZERS 53
6.1.4 CHOLESTEROL ANALYZERS 56
7 NEUROMONITORING DEVICES 59
7.1 INTRODUCTION 60
7.1.1 ELECTROENCEPHALOGRAPH (EEG) 61
7.1.2 TRANSCRANIAL DOPPLER (TCD) 63
7.1.3 MAGNETOENCEPHALOGRAPH (MEG) 65
7.1.4 CEREBRAL OXIMETERS 67
7.1.5 INTRACRANIAL PRESSURE MONITORS (ICP) 69
8 CARDIAC MONITORING DEVICES 71
8.1 INTRODUCTION 72
8.2 ELECTROCARDIOGRAM (ECG) 73
8.3 ECG MARKET, BY PRODUCT TYPE 75
8.3.1 RESTING ECG 76
8.3.1.1 Stress ECG 76
8.3.1.2 Holter monitor 76
8.3.2 WIRED HOLTER MONITORS 76
8.3.3 WIRELESS HOLTER MONITORS 76
8.4 ECG DEVICES MARKET, BY LEAD TYPE 77
8.4.1 SINGLE-LEAD ECG DEVICES 78
8.4.2 3–6 LEAD ECG DEVICES 78
8.4.3 12-LEAD ECG DEVICES 78
8.4.4 OTHERS 78
8.5 EVENT MONITORS 79
8.6 EVENT MONITORS MARKET, BY PRODUCT TYPE 80
8.6.1 PRE-SYMPTOM (MEMORY LOOP) 81
8.6.2 POST-SYMPTOM EVENT MONITORS 81
8.7 EVENT MONITORS MARKET, BY TECHNOLOGY 82
8.7.1 AUTODETECT MONITORS 82
8.7.2 MANUAL EVENT MONITOR 83
8.8 IMPLANTABLE LOOP RECORDER (ILR) 84
8.9 CARDIAC OUTPUT MONITORING DEVICES 84
8.9.1 MINIMALLY INVASIVE COM DEVICES 85
8.9.2 NON-INVASIVE COM DEVICES 86
9 FETAL AND NEONATAL MONITORING DEVICES 87
9.1 INTRODUCTION 88
9.2 ULTRA SOUND FETAL DOPPLERS 90
9.3 INTERNAL FETAL MONITORS 91
10 RESPIRATORY MONITORING DEVICES 93
10.1 INTRODUCTION 94
10.2 CAPNOGRAPHS 96
10.3 SPIROMETERS 99
10.4 ANESTHESIA MONITORS 102
10.5 SLEEP APNEA MONITORING DEVICES 104
10.6 PULSE OXIMETERS 106
11 MULTI-PARAMETER MONITORING DEVICES 109
11.1 INTRODUCTION 110
11.2 HIGH-ACUITY MONITORS 113
11.3 MID-ACUITY MONITORS 113
11.4 LOW-ACUITY MONITORS 114
12 REMOTE PATIENT MONITORING DEVICES MARKET 115
12.1 INTRODUCTION 116
13 WEIGHT MONITORING DEVICES 118
13.1 INTRODUCTION 119
14 TEMPERATURE MONITORING DEVICES 122
14.1 INTRODUCTION 123
15 PATIENT MONITORING DEVICES MARKET, BY REGION 126
15.1 INTRODUCTION 127
15.2 NORTH AMERICA 129
15.3 EUROPE 134
15.4 ASIA-PACIFIC 138
15.5 REST OF THE WORLD 143
16 COMPETITIVE LANDSCAPE 147
16.1 OVERVIEW 147
16.2 MARKET SHARE ANALYSIS 148
16.2.1 HEMODYNAMIC MONITORS 148
16.2.1.1 Blood pressure monitors 148
16.2.1.2 Single-point blood glucose monitors 149
16.2.1.3 Continuous blood glucose monitors 149
16.2.1.4 Blood gas and electrolyte analyzers 150
16.2.2 NEUROLOGICAL MONITORS 151
16.2.2.1 Electroencephalographs (EEG) 151
16.2.2.2 Transcranial Doppler (TCD) 152
16.2.2.3 Magnetoencephalographs (MEG) 152
16.2.2.4 Cerebral oximetry monitors 153
16.2.2.5 Intracranial pressure (ICP) monitors (Top Players) 154
16.2.3 CARDIAC MONITORS 155
16.2.3.1 Electrocardiographs (ECG) 155
16.2.3.2 Event monitors 156
16.2.3.3 Cardiac output monitors 156
16.2.4 RESPIRATORY MONITORING DEVICES 157
16.2.4.1 Capnographs 157
16.2.4.2 Spirometers 157
16.2.4.3 Anesthesia monitors 158
16.2.4.4 Sleep apnea monitors 158
16.2.4.5 Pulse oximeters 159
16.2.5 FETAL & NEONATAL MONITORS 159
16.2.6 MULTI-PARAMETER MONITORS 160
16.3 COMPETITIVE SITUATION AND TRENDS 161
16.3.1 NEW PRODUCT LAUNCHES AND APPROVALS 161
16.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 162
16.3.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012-2015 162
16.3.4 ACQUISITIONS AND EXPANSIONS 163
16.3.5 OTHER DEVELOPMENTS 164
17 COMPANY PROFILES 165
17.1 INTRODUCTION 165
17.2 ABBOTT LABORATORIES 166
17.3 ROCHE DIAGNOSTICS 169
17.4 SIEMENS HEALTHCARE 172
17.5 GE HEALTHCARE 175
17.6 MEDTRONIC PLC 178
17.7 PHILIPS HEALTHCARE 182
17.8 LIFEWATCH AG 185
17.9 NIHON KOHDEN CORPORATION 188
17.10 OMRON CORPORATION 190
17.11 HONEYWELL INTERNATIONAL, INC. 192
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
18 APPENDIX 194
18.1 INSIGHTS OF INDUSTRY EXPERTS 194
18.2 DISCUSSION GUIDE 194
18.3 OTHER DEVELOPMENTS 197
18.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 202
18.5 AVAILABLE CUSTOMIZATIONS 204
18.6 RELATED REPORTS 204